Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Balasch, J; Creus, M; Fabregues, F; Civico, S; Carmona, F; Puerto, B; Casamitjana, R; Vanrell, JA
   The effect of exogenous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction
   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
   
   J. Balasch et al., "The effect of exogenous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction", J AS REPROD, 18(5), 2001, pp. 250-256
2. Carmona, F; Font, J; Azulay, M; Creus, M; Fabregues, F; Cervera, R; Puerto, B; Balasch, J
   Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis
   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
   
   F. Carmona et al., "Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis", AM J REPROD, 46(4), 2001, pp. 274-279
3. Balasch, J; Vidal, E; Penarrubia, J; Casamitjana, R; Carmona, F; Creus, M; Fabregues, F; Vanrell, JA
   Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH
   HUMAN REPRODUCTION
   
   J. Balasch et al., "Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH", HUM REPR, 16(8), 2001, pp. 1636-1643
4. Creus, M; Ordi, J; Fabregues, F; Casamitjana, R; Vanrell, JA; Balasch, J
   Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation
   HUMAN REPRODUCTION
   
   M. Creus et al., "Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation", HUM REPR, 16(7), 2001, pp. 1347-1352
5. Balasch, J; Fabregues, F; Creus, M; Puerto, B; Penarrubia, J; Vanrell, JA
   Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modifiedstep-down regimens
   HUMAN REPRODUCTION
   
   J. Balasch et al., "Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modifiedstep-down regimens", HUM REPR, 16(4), 2001, pp. 652-656
6. Balasch, J; Fabregues, F; Creus, M; Casamitjana, R; Puerto, B; Vanrell, JA
   Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol
   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
   
   J. Balasch et al., "Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol", J AS REPROD, 17(10), 2000, pp. 561-565
7. Fabregues, F; Balasch, J; Creus, M; Carmona, F; Puerto, B; Quinto, L; Casamitjana, R; Vanrell, JA
   Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome
   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
   
   F. Fabregues et al., "Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome", J AS REPROD, 17(1), 2000, pp. 13-19
8. Balasch, J; Fabregues, F; Creus, M; Penarrubia, J; Vidal, E; Carmona, F; Puerto, B; Vanrell, JA
   Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential
   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
   
   J. Balasch et al., "Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential", J AS REPROD, 17(1), 2000, pp. 20-27
9. Ballesca, JL; Balasch, J; Calafell, JM; Alvarez, R; Fabregues, F; de Osaba, MJM; Ascaso, C; Vanrell, JA
   Serum inhibin B determination is predictive of successful testicular spermextraction in men with non-obstructive azoospermia
   HUMAN REPRODUCTION
   
   J.L. Ballesca et al., "Serum inhibin B determination is predictive of successful testicular spermextraction in men with non-obstructive azoospermia", HUM REPR, 15(8), 2000, pp. 1734-1738
10. Penarrubia, J; Balasch, J; Fabregues, F; Carmona, F; Casamitjana, R; Moreno, V; Calafell, JM; Vanrell, JA
    Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment
    HUMAN REPRODUCTION
    
    J. Penarrubia et al., "Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment", HUM REPR, 15(7), 2000, pp. 1499-1504
11. Manau, D; Balasch, J; Jimenez, W; Fabregues, F; Civico, S; Casamitjana, R; Creus, M; Vanrell, JA
    Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response
    HUMAN REPRODUCTION
    
    D. Manau et al., "Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response", HUM REPR, 15(6), 2000, pp. 1295-1299
12. Creus, M; Penarrubia, J; Fabregues, F; Vidal, E; Carmona, F; Casamitjana, R; Vanrell, JA; Balasch, J
    Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome
    HUMAN REPRODUCTION
    
    M. Creus et al., "Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome", HUM REPR, 15(11), 2000, pp. 2341-2346
13. Out, HJ; Braat, DDM; Lintsen, BME; Gurgan, T; Bukulmez, O; Gokmen, O; Keles, G; Caballero, P; Gonzalez, JM; Fabregues, F; Balasch, J; Roulier, R
    Increasing the daily dose of recombinant follicle stimulating hormone (Puregon((R))) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation
    HUMAN REPRODUCTION
    
    H.J. Out et al., "Increasing the daily dose of recombinant follicle stimulating hormone (Puregon((R))) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation", HUM REPR, 15(1), 2000, pp. 29-35
14. Fabregues, F; Balasch, J; Manau, D; Creus, M; Jimenez, W; Carmona, F; Casamitjana, R; Vanrell, JA
    Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    
    F. Fabregues et al., "Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone", ACT OBST SC, 79(7), 2000, pp. 564-569
15. Balasch, J; Reverter, JC; Creus, M; Tassies, D; Fabregues, F; Carmona, F; Font, J; Vanrell, JA
    Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)
    HUMAN REPRODUCTION
    
    J. Balasch et al., "Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)", HUM REPR, 14(8), 1999, pp. 1956-1959
16. Penarrubia, J; Balasch, J; Fabregues, F; Creus, M; Civico, S; Vanrell, JA
    Recurrent empty follicle syndrome successfully treated with recombinant human chorionic, gonadotrophin
    HUMAN REPRODUCTION
    
    J. Penarrubia et al., "Recurrent empty follicle syndrome successfully treated with recombinant human chorionic, gonadotrophin", HUM REPR, 14(7), 1999, pp. 1703-1706
17. Fabregues, F; Balasch, J; Gines, P; Manau, D; Jimenez, W; Arroyo, V; Creus, M; Vanrell, JA
    Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    F. Fabregues et al., "Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome", AM J GASTRO, 94(4), 1999, pp. 994-999
18. Manau, D; Balasch, J; Jimenez, W; Fabregues, F; Casamitjana, R; Creus, M; Arroyo, V; Vanrell, JA
    Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    
    D. Manau et al., "Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol", ACT OBST SC, 78(7), 1999, pp. 626-631
19. BALASCH J; FABREGUES F; PENARRUBIA J; CREUS M; VIDAL R; CASAMITJANA R; MANAU D; VANRELL JA
    FOLLICULAR DEVELOPMENT AND HORMONAL LEVELS FOLLOWING HIGHLY PURIFIED OR RECOMBINANT FOLLICLE-STIMULATING-HORMONE ADMINISTRATION IN OVULATORY WOMEN AND WHO GROUP-II ANOVULATORY INFERTILE PATIENTS
    Journal of assisted reproduction and genetics
    
    J. Balasch et al., "FOLLICULAR DEVELOPMENT AND HORMONAL LEVELS FOLLOWING HIGHLY PURIFIED OR RECOMBINANT FOLLICLE-STIMULATING-HORMONE ADMINISTRATION IN OVULATORY WOMEN AND WHO GROUP-II ANOVULATORY INFERTILE PATIENTS", Journal of assisted reproduction and genetics, 15(9), 1998, pp. 552-559
20. BALASCH J; CREUS M; FABREGUES F; CIVICO S; REVERTER JC; CARMONA F; TASSIES D; VANRELL JA
    ANTIPHOSPHOLIPID ANTIBODIES AND THE OUTCOME OF PREGNANCY AFTER THE FIRST IN-VITRO FERTILIZATION AND EMBRYO-TRANSFER CYCLE
    Human reproduction
    
    J. Balasch et al., "ANTIPHOSPHOLIPID ANTIBODIES AND THE OUTCOME OF PREGNANCY AFTER THE FIRST IN-VITRO FERTILIZATION AND EMBRYO-TRANSFER CYCLE", Human reproduction, 13(5), 1998, pp. 1180-1183
21. CREUS M; BALASCH J; FABREGUES F; MARTORELL J; BOADA M; PENARRUBIA J; BARRI PN; VANRELL JA
    PARENTAL HUMAN-LEUKOCYTE ANTIGENS AND IMPLANTATION FAILURE AFTER IN-VITRO FERTILIZATION
    Human reproduction
    
    M. Creus et al., "PARENTAL HUMAN-LEUKOCYTE ANTIGENS AND IMPLANTATION FAILURE AFTER IN-VITRO FERTILIZATION", Human reproduction, 13(1), 1998, pp. 39-43
22. MANAU D; BALASCH J; ARROYO V; JIMENEZ W; FABREGUES F; CASAMITJANA R; CREUS M; VANRELL JA
    CIRCULATORY DYSFUNCTION IS A UNIVERSAL EVENT IN ASYMPTOMATIC IVF PATIENTS
    Human reproduction (Oxford. Print)
    
    D. Manau et al., "CIRCULATORY DYSFUNCTION IS A UNIVERSAL EVENT IN ASYMPTOMATIC IVF PATIENTS", Human reproduction (Oxford. Print), 13, 1998, pp. 223-223
23. Fabregues, F; Balasch, J; Manau, D; Jimenez, W; Arroyo, V; Creus, M; Rivera, F; Vanrell, JA
    Haematocrit, leukocyte and platelet counts and the severity of the ovarianhyperstimulation syndrome
    HUMAN REPRODUCTION
    
    F. Fabregues et al., "Haematocrit, leukocyte and platelet counts and the severity of the ovarianhyperstimulation syndrome", HUM REPR, 13(9), 1998, pp. 2406-2410
24. Penarrubia, J; Balasch, J; Fabregues, F; Creus, M; Casamitjana, R; Ballesca, JL; Puerto, B; Vanrell, JA
    Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles
    HUMAN REPRODUCTION
    
    J. Penarrubia et al., "Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles", HUM REPR, 13(12), 1998, pp. 3315-3318
25. Creus, M; Balasch, J; Ordi, J; Fabregues, F; Casamitjana, R; Quinto, L; Coutifaris, C; Vanrell, JA
    Integrin expression in normal and out-of-phase endometria
    HUMAN REPRODUCTION
    
    M. Creus et al., "Integrin expression in normal and out-of-phase endometria", HUM REPR, 13(12), 1998, pp. 3460-3468
26. Balasch, J; Fabregues, F; Arroyo, V
    Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome
    HUMAN REPRODUCTION
    
    J. Balasch et al., "Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome", HUM REPR, 13(10), 1998, pp. 2718-2730
27. MANAU D; BALASCH J; ARROYO V; JIMENEZ W; FABREGUES F; CASAMITJANA R; CREUS N; VANRELL JA
    CIRCULATORY DYSFUNCTION IN ASYMPTOMATIC IN-VITRO FERTILIZATION PATIENTS - RELATIONSHIP WITH HYPERESTROGENEMIA AND ACTIVITY OF ENDOGENOUS VASODILATORS
    The Journal of clinical endocrinology and metabolism
    
    D. Manau et al., "CIRCULATORY DYSFUNCTION IN ASYMPTOMATIC IN-VITRO FERTILIZATION PATIENTS - RELATIONSHIP WITH HYPERESTROGENEMIA AND ACTIVITY OF ENDOGENOUS VASODILATORS", The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1489-1493
28. FABREGUES F; BALASCH J; CREUS M; CIVICO S; CARMONA F; PUERTO B; VANRELL JA
    LONG-TERM DOWN-REGULATION DOES NOT IMPROVE PREGNANCY RATES IN AN IN-VITRO FERTILIZATION PROGRAM
    Fertility and sterility
    
    F. Fabregues et al., "LONG-TERM DOWN-REGULATION DOES NOT IMPROVE PREGNANCY RATES IN AN IN-VITRO FERTILIZATION PROGRAM", Fertility and sterility, 70(1), 1998, pp. 46-51
29. MARTINEZROMAN S; BALASCH J; CREUS M; FABREGUES F; CARMONA F; VILELLA R; VANRELL JA
    TRANSFERRIN RECEPTOR (CD71) EXPRESSION IN PERITONEAL-MACROPHAGES FROMFERTILE AND INFERTILE WOMEN WITH AND WITHOUT ENDOMETRIOSIS
    American journal of reproductive immunology [1989]
    
    S. Martinezroman et al., "TRANSFERRIN RECEPTOR (CD71) EXPRESSION IN PERITONEAL-MACROPHAGES FROMFERTILE AND INFERTILE WOMEN WITH AND WITHOUT ENDOMETRIOSIS", American journal of reproductive immunology [1989], 38(6), 1997, pp. 413-417
30. BALASCH J; FABREGUES F; CREUS M; VANRELL JA
    SEQUENTIAL DANAZOL LEUPROLIDE ACETATE THERAPY FOR OVARIAN SUPPRESSIONIN AN IN-VITRO FERTILIZATION PATIENT UNRESPONSIVE TO LEUPROLIDE ACETATE/
    Gynecological endocrinology
    
    J. Balasch et al., "SEQUENTIAL DANAZOL LEUPROLIDE ACETATE THERAPY FOR OVARIAN SUPPRESSIONIN AN IN-VITRO FERTILIZATION PATIENT UNRESPONSIVE TO LEUPROLIDE ACETATE/", Gynecological endocrinology, 11(1), 1997, pp. 21-24
31. BALASCH J; CREUS M; FABREGUES F; CARMONA F; MARTINEZROMAN S; MANAU D; VANRELL JA
    PENTOXIFYLLINE VERSUS PLACEBO IN THE TREATMENT OF INFERTILITY ASSOCIATED WITH MINIMAL OR MILD ENDOMETRIOSIS - A PILOT RANDOMIZED CLINICAL-TRIAL
    Human reproduction
    
    J. Balasch et al., "PENTOXIFYLLINE VERSUS PLACEBO IN THE TREATMENT OF INFERTILITY ASSOCIATED WITH MINIMAL OR MILD ENDOMETRIOSIS - A PILOT RANDOMIZED CLINICAL-TRIAL", Human reproduction, 12(9), 1997, pp. 2046-2050
32. MARTINEZROMAN S; BALASCH J; CREUS M; FABREGUES F; CARMONA F; VILELLA R; VANRELL JA
    IMMUNOLOGICAL FACTORS IN ENDOMETRIOSIS-ASSOCIATED REPRODUCTIVE FAILURE - STUDIES IN FERTILE AND INFERTILE WOMEN WITH AND WITHOUT ENDOMETRIOSIS
    Human reproduction
    
    S. Martinezroman et al., "IMMUNOLOGICAL FACTORS IN ENDOMETRIOSIS-ASSOCIATED REPRODUCTIVE FAILURE - STUDIES IN FERTILE AND INFERTILE WOMEN WITH AND WITHOUT ENDOMETRIOSIS", Human reproduction, 12(8), 1997, pp. 1794-1799
33. BALASCH J; REVERTER JC; FABREGUES F; TASSIES D; RAFEL M; CREUS M; VANRELL JA
    FIRST-TRIMESTER REPEATED ABORTION IS NOT ASSOCIATED WITH ACTIVATED PROTEIN-C RESISTANCE
    Human reproduction
    
    J. Balasch et al., "FIRST-TRIMESTER REPEATED ABORTION IS NOT ASSOCIATED WITH ACTIVATED PROTEIN-C RESISTANCE", Human reproduction, 12(5), 1997, pp. 1094-1097
34. BALASCH J; FABREGUES F; ORDI J; CREUS M; PENARRUBIA J; CASAMITJANA R; MANAU D; VANRELL CA
    FURTHER DATA FAVORING THE HYPOTHESIS OF THE UTERINE FIRST-PASS EFFECTOF VAGINALLY ADMINISTERED MICRONIZED PROGESTERONE
    Gynecological endocrinology
    
    J. Balasch et al., "FURTHER DATA FAVORING THE HYPOTHESIS OF THE UTERINE FIRST-PASS EFFECTOF VAGINALLY ADMINISTERED MICRONIZED PROGESTERONE", Gynecological endocrinology, 10(6), 1996, pp. 421-426
35. BALASCH J; CREUS M; FABREGUES F; CIVICO S; CARMONA F; MARTORELL J; VANRELL JA
    IN-VITRO FERTILIZATION TREATMENT FOR UNEXPLAINED RECURRENT ABORTION -A PILOT-STUDY
    Human reproduction
    
    J. Balasch et al., "IN-VITRO FERTILIZATION TREATMENT FOR UNEXPLAINED RECURRENT ABORTION -A PILOT-STUDY", Human reproduction, 11(7), 1996, pp. 1579-1582
36. BALASCH J; CREUS M; FABREGUES F; CARMONA F; ORDI J; MARTINEZROMAN S; VANRELL JA
    VISIBLE AND NON-VISIBLE ENDOMETRIOSIS AT LAPAROSCOPY IN FERTILE AND INFERTILE WOMEN AND IN PATIENTS WITH CHRONIC PELVIC PAIN - A PROSPECTIVE-STUDY
    Human reproduction
    
    J. Balasch et al., "VISIBLE AND NON-VISIBLE ENDOMETRIOSIS AT LAPAROSCOPY IN FERTILE AND INFERTILE WOMEN AND IN PATIENTS WITH CHRONIC PELVIC PAIN - A PROSPECTIVE-STUDY", Human reproduction, 11(2), 1996, pp. 387-391
37. BALASCH J; CREUS M; FABREGUES F; CASAMITJANA R; ORDI J; VANRELL JA
    MIDLUTEAL IMMUNOREACTIVE ALPHA-INHIBIN SERUM CONCENTRATIONS AS MARKERS OF LUTEAL-PHASE DEFICIENCY
    Human reproduction
    
    J. Balasch et al., "MIDLUTEAL IMMUNOREACTIVE ALPHA-INHIBIN SERUM CONCENTRATIONS AS MARKERS OF LUTEAL-PHASE DEFICIENCY", Human reproduction, 11(12), 1996, pp. 2591-2594
38. BALASCH J; CREUS M; FABREGUES F; REVERTER JC; CARMONA F; TASSIES D; FONT J; VANRELL JA
    ANTIPHOSPHOLIPID ANTIBODIES AND HUMAN REPRODUCTIVE FAILURE
    Human reproduction
    
    J. Balasch et al., "ANTIPHOSPHOLIPID ANTIBODIES AND HUMAN REPRODUCTIVE FAILURE", Human reproduction, 11(10), 1996, pp. 2310-2315
39. BALASCH J; REVERTER JC; FABREGUES F; TASSIES D; ORDINAS A; VANRELL JA
    INCREASED INDUCED MONOCYTE TISSUE FACTOR EXPRESSION BY PLASMA FROM PATIENTS WITH SEVERE OVARIAN HYPERSTIMULATION SYNDROME
    Fertility and sterility
    
    J. Balasch et al., "INCREASED INDUCED MONOCYTE TISSUE FACTOR EXPRESSION BY PLASMA FROM PATIENTS WITH SEVERE OVARIAN HYPERSTIMULATION SYNDROME", Fertility and sterility, 66(4), 1996, pp. 608-613
40. BALASCH J; CREUS M; FABREGUES F; FONT J; MARTORELL J; VANRELL JA
    INTRAVENOUS IMMUNOGLOBULIN PRECEDING IN-VITRO FERTILIZATION-EMBRYO TRANSFER FOR PATIENTS WITH REPEATED FAILURE OF EMBRYO-TRANSFER
    Fertility and sterility
    
    J. Balasch et al., "INTRAVENOUS IMMUNOGLOBULIN PRECEDING IN-VITRO FERTILIZATION-EMBRYO TRANSFER FOR PATIENTS WITH REPEATED FAILURE OF EMBRYO-TRANSFER", Fertility and sterility, 65(3), 1996, pp. 655-658
41. BALASCH J; CREUS M; FABREGUES F; CARMONA F; CASAMITJANA R; ASCASO C; VANRELL JA
    INHIBIN, FOLLICLE-STIMULATING-HORMONE, AND AGE AS PREDICTORS OF OVARIAN RESPONSE IN IN-VITRO FERTILIZATION CYCLES STIMULATED WITH GONADOTROPIN-RELEASING-HORMONE AGONIST GONADOTROPIN TREATMENT
    American journal of obstetrics and gynecology
    
    J. Balasch et al., "INHIBIN, FOLLICLE-STIMULATING-HORMONE, AND AGE AS PREDICTORS OF OVARIAN RESPONSE IN IN-VITRO FERTILIZATION CYCLES STIMULATED WITH GONADOTROPIN-RELEASING-HORMONE AGONIST GONADOTROPIN TREATMENT", American journal of obstetrics and gynecology, 175(5), 1996, pp. 1226-1230
42. BALASCH J; FABREGUES F; ARROYO V; JIMENEZ W; CREUS M; VANRELL JA
    TREATMENT OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME BY A CONSERVATIVE MEDICAL APPROACH
    Acta obstetricia et gynecologica Scandinavica
    
    J. Balasch et al., "TREATMENT OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME BY A CONSERVATIVE MEDICAL APPROACH", Acta obstetricia et gynecologica Scandinavica, 75(7), 1996, pp. 662-667
43. BALASCH J; CREUS M; FABREGUES F; CARMONA F; CASAMITJANA R; PENARRUBIA J; RIVERA F; VANRELL JA
    HORMONAL PROFILES IN SUCCESSFUL AND UNSUCCESSFUL IMPLANTATION IN IVF-ET AFTER COMBINED GNRH AGONIST GONADOTROPIN TREATMENT FOR SUPEROVULATION AND HCG LUTEAL SUPPORT
    Gynecological endocrinology
    
    J. Balasch et al., "HORMONAL PROFILES IN SUCCESSFUL AND UNSUCCESSFUL IMPLANTATION IN IVF-ET AFTER COMBINED GNRH AGONIST GONADOTROPIN TREATMENT FOR SUPEROVULATION AND HCG LUTEAL SUPPORT", Gynecological endocrinology, 9(1), 1995, pp. 51-58
44. BALASCH J; FABREGUES F; TUR R; CREUS M; CASAMITJANA R; PENARRUBIA J; BARRI PN; VANRELL JA
    FURTHER CHARACTERIZATION OF THE LUTEAL-PHASE INADEQUACY AFTER GONADOTROPIN-RELEASING-HORMONE AGONIST-INDUCED OVULATION IN GONADOTROPIN-STIMULATED CYCLES
    Human reproduction
    
    J. Balasch et al., "FURTHER CHARACTERIZATION OF THE LUTEAL-PHASE INADEQUACY AFTER GONADOTROPIN-RELEASING-HORMONE AGONIST-INDUCED OVULATION IN GONADOTROPIN-STIMULATED CYCLES", Human reproduction, 10(6), 1995, pp. 1377-1381
45. BALASCH J; ARROYO V; FABREGUES F; JIMENEZ W; SALO J; VANRELL JA
    IMMUNOREACTIVE ENDOTHELIN PLASMA-LEVELS IN SEVERE OVARIAN HYPERSTIMULATION SYNDROME
    Fertility and sterility
    
    J. Balasch et al., "IMMUNOREACTIVE ENDOTHELIN PLASMA-LEVELS IN SEVERE OVARIAN HYPERSTIMULATION SYNDROME", Fertility and sterility, 64(1), 1995, pp. 65-68
46. BALASCH J; TUR R; CREUS M; BUXADERAS R; FABREGUES F; BALLESCA JL; BARRI PN; VANRELL JA
    TRIGGERING OF OVULATION BY A GONADOTROPIN-RELEASING-HORMONE AGONIST IN GONADOTROPIN-STIMULATED CYCLES FOR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME AND MULTIPLE PREGNANCY
    Gynecological endocrinology
    
    J. Balasch et al., "TRIGGERING OF OVULATION BY A GONADOTROPIN-RELEASING-HORMONE AGONIST IN GONADOTROPIN-STIMULATED CYCLES FOR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME AND MULTIPLE PREGNANCY", Gynecological endocrinology, 8(1), 1994, pp. 7-12
47. BALASCH J; BALLESCA JL; PIMENTEL C; CREUS M; FABREGUES F; VANRELL JA
    LATE LOW-DOSE PURE FOLLICLE-STIMULATING-HORMONE FOR OVARIAN STIMULATION IN INTRAUTERINE INSEMINATION CYCLES
    Human reproduction
    
    J. Balasch et al., "LATE LOW-DOSE PURE FOLLICLE-STIMULATING-HORMONE FOR OVARIAN STIMULATION IN INTRAUTERINE INSEMINATION CYCLES", Human reproduction, 9(10), 1994, pp. 1863-1866
48. BALASCH J; BALLESCA JL; PIMENTEL C; CREUS M; FABREGUES F; VANRELL JA
    LATE LOW-DOSE PURE FOLLICLE-STIMULATING-HORMONE FOR OVARIAN STIMULATION IN INTRAUTERINE INSEMINATION CYCLES
    Human reproduction
    
    J. Balasch et al., "LATE LOW-DOSE PURE FOLLICLE-STIMULATING-HORMONE FOR OVARIAN STIMULATION IN INTRAUTERINE INSEMINATION CYCLES", Human reproduction, 9(10), 1994, pp. 1863-1866
49. TORNE A; PAHISA J; CASTELOBRANCO C; FABREGUES F; MALLOFRE C; IGLESIAS X
    SOLITARY VAGINAL METASTASIS AS A PRESENTING FORM OF UNSUSPECTED RENALADENOCARCINOMA
    Gynecologic oncology
    
    A. Torne et al., "SOLITARY VAGINAL METASTASIS AS A PRESENTING FORM OF UNSUSPECTED RENALADENOCARCINOMA", Gynecologic oncology, 52(2), 1994, pp. 260-263
50. BALASCH J; ARROYO V; FABREGUES F; SALO J; JIMENEZ W; PARE JC; VANRELL JA
    NEUROHORMONAL AND HEMODYNAMIC-CHANGES IN SEVERE CASES OF THE OVARIAN HYPERSTIMULATION SYNDROME
    Annals of internal medicine
    
    J. Balasch et al., "NEUROHORMONAL AND HEMODYNAMIC-CHANGES IN SEVERE CASES OF THE OVARIAN HYPERSTIMULATION SYNDROME", Annals of internal medicine, 121(1), 1994, pp. 27-33
51. BALASCH J; PAHISA J; MARQUEZ M; ORDI J; FABREGUES F; PUERTO B; VANRELL JA
    METASTATIC OVARIAN STRUMOSIS IN AN IN-VITRO FERTILIZATION PATIENT
    Human reproduction
    
    J. Balasch et al., "METASTATIC OVARIAN STRUMOSIS IN AN IN-VITRO FERTILIZATION PATIENT", Human reproduction, 8(12), 1993, pp. 2075-2079
52. BALASCH J; CARMONA F; LOPEZSOTO A; FONT J; CREUS M; FABREGUES F; INGELMO M; VANRELL JA
    LOW-DOSE ASPIRIN FOR PREVENTION OF PREGNANCY LOSSES IN WOMEN WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
    Human reproduction
    
    J. Balasch et al., "LOW-DOSE ASPIRIN FOR PREVENTION OF PREGNANCY LOSSES IN WOMEN WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME", Human reproduction, 8(12), 1993, pp. 2234-2239